Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting-Reference-Cited by-同舟云学术

Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve patients with type 2 diabetes after failure of oral therapy in a real‐world setting

Published:2020-01-24 Issue:5 Volume:22 Page:759-766
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Pfohl Martin¹,Jornayvaz François R.²,Fritsche Andreas³⁴,Pscherer Stefan⁵,Anderten Helmut⁶,Pegelow Katrin⁷,Seufert Jochen⁸^ORCID

Affiliation:

1. Department of Internal Medicine I, Evang. Bethesda‐Hospital Duisburg Duisburg Germany

2. Department of Endocrinology, Diabetology, Hypertension and NutritionUniversity Hospital of Geneva Geneva Switzerland

3. Department of Internal Medicine IVUniversity of Tuebingen Tuebingen Germany

4. Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tuebingen (IDM) Tuebingen Germany

5. Department of Internal Medicine IIISophien‐ and Hufeland‐Hospital Weimar Germany

6. Joint Practice Anderten‐Krok & Partner Hildesheim Germany

7. Sanofi‐Aventis Deutschland GmbH Berlin Germany

8. Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of FreiburgFaculty of Medicine, University of Freiburg Germany

Funder

Deutsche Diabetes Gesellschaft

American Diabetes Association

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13952

Reference17 articles.

1. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies

2. Burden of Illness in Type 2 Diabetes Mellitus